Campos RamÃrez, S.E.; Andrés GarcÃa, A.; Blanco Abad, C.; Gomila Pons, P.; Gómez Mugarza, P.; Ruffini Egea, S.E.; Gallart Caballero, L.; Polo Marques, E.; Alonso Orduña, V.
Evaluation of the Real-Life Efficacy and Safety of the Treatment with Lutetium-177 Dotatate for Metastatic Neuroendocrine Tumors. J. Clin. Med. 2025, 14, 2384.
https://doi.org/10.3390/jcm14072384
AMA Style
Campos RamÃrez SE, Andrés GarcÃa A, Blanco Abad C, Gomila Pons P, Gómez Mugarza P, Ruffini Egea SE, Gallart Caballero L, Polo Marques E, Alonso Orduña V.
Evaluation of the Real-Life Efficacy and Safety of the Treatment with Lutetium-177 Dotatate for Metastatic Neuroendocrine Tumors. Journal of Clinical Medicine. 2025; 14(7):2384.
https://doi.org/10.3390/jcm14072384
Chicago/Turabian Style
Campos RamÃrez, Sara Elena, Alejandro Andrés GarcÃa, Carmen Blanco Abad, Paula Gomila Pons, Pablo Gómez Mugarza, SofÃa Elena Ruffini Egea, Luis Gallart Caballero, Eduardo Polo Marques, and Vicente Alonso Orduña.
2025. "Evaluation of the Real-Life Efficacy and Safety of the Treatment with Lutetium-177 Dotatate for Metastatic Neuroendocrine Tumors" Journal of Clinical Medicine 14, no. 7: 2384.
https://doi.org/10.3390/jcm14072384
APA Style
Campos RamÃrez, S. E., Andrés GarcÃa, A., Blanco Abad, C., Gomila Pons, P., Gómez Mugarza, P., Ruffini Egea, S. E., Gallart Caballero, L., Polo Marques, E., & Alonso Orduña, V.
(2025). Evaluation of the Real-Life Efficacy and Safety of the Treatment with Lutetium-177 Dotatate for Metastatic Neuroendocrine Tumors. Journal of Clinical Medicine, 14(7), 2384.
https://doi.org/10.3390/jcm14072384
